RBC Bioscience Corporation (6848.TWO)
TWD 18.0
(-9.09%)
TWD 18.0
(-9.09%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 753.79 Million TWD | -4.65% |
| 2022 | 790.54 Million TWD | -6.73% |
| 2021 | 847.6 Million TWD | 65.35% |
| 2020 | 512.61 Million TWD | 155.1% |
| 2019 | 200.95 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 771.71 Million TWD | 0.0% |
| 2024 Q1 | 771.71 Million TWD | 2.38% |
| 2023 Q2 | 763.19 Million TWD | 0.0% |
| 2023 Q4 | 753.79 Million TWD | 0.0% |
| 2023 FY | 753.79 Million TWD | -4.65% |
| 2023 Q1 | 763.19 Million TWD | -3.46% |
| 2023 Q3 | 753.79 Million TWD | -1.23% |
| 2022 Q3 | 790.54 Million TWD | 0.0% |
| 2022 FY | 790.54 Million TWD | -6.73% |
| 2022 Q4 | 790.54 Million TWD | 0.0% |
| 2021 FY | 847.6 Million TWD | 65.35% |
| 2020 FY | 512.61 Million TWD | 155.1% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -488.682% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 74.015% |
| Level Biotechnology Inc. | 822.67 Million TWD | 8.373% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -13.399% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -37.365% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 80.642% |
| GlycoNex Incorporation | 1.55 Billion TWD | 51.457% |
| VBI | 452.1 Million TWD | -66.73% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 35.91% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -0.697% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -99.225% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 33.519% |
| Visgeneer Inc. | 397.17 Million TWD | -89.787% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 80.008% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 65.087% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 14.642% |
| Neith Corporation | 192.15 Million TWD | -292.286% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 87.628% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -924.756% |
| Enimmune corporation | 604.82 Million TWD | -24.629% |
| TaiRx, Inc. | 833.74 Million TWD | 9.59% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 75.574% |
| EirGenix Inc. | 11.16 Billion TWD | 93.247% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -31.52% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 55.98% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 79.042% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 28.243% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -150.402% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -184.818% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -70.853% |
| BiOptic Inc. | 613.77 Million TWD | -22.813% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 57.621% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 35.002% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -16.894% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 75.733% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -409.545% |
| NaviFUS Corp. | 490.53 Million TWD | -53.667% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 38.502% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 44.711% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -42.454% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 35.096% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 54.489% |
| AP Biosciences Inc | 890.75 Million TWD | 15.376% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 91.16% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -132.545% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 43.479% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 72.196% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 95.094% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -83.736% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -89.943% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 63.689% |
| TCI GENE Inc. | 1.16 Billion TWD | 35.349% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -155.885% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 44.71% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 19.96% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -7.923% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 80.936% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 80.281% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 38.708% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 86.549% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 29.022% |
| Acepodia, Inc. | 6.81 Billion TWD | 88.945% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 80.301% |